Compare AIOS & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIOS | BEAT |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | China | United States |
| Employees | 20 | 16 |
| Industry | Metal Fabrications | Retail: Computer Software & Peripheral Equipment |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.9M | 53.2M |
| IPO Year | N/A | N/A |
| Metric | AIOS | BEAT |
|---|---|---|
| Price | $12.67 | $0.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | 60.3K | ★ 549.3K |
| Earning Date | 04-20-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $315.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.39 | $0.54 |
| 52 Week High | $33.87 | $4.00 |
| Indicator | AIOS | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 50.05 | 37.79 |
| Support Level | $13.01 | $0.54 |
| Resistance Level | $16.40 | $0.94 |
| Average True Range (ATR) | 2.01 | 0.06 |
| MACD | -0.52 | -0.01 |
| Stochastic Oscillator | 45.61 | 24.41 |
AIOS Tech Inc is a provider of artificial intelligence and technology-driven professional services. The Company is focused on delivering information technology solutions, data services, and artificial intelligence-powered offerings to a diverse commercial client base. Its core businesses include digital transformation services, tailored IT solutions for the financial sector, enterprise data solutions, and the development of AI platforms and infrastructure to drive efficiency and growth for clients across multiple industries.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.